These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6820097)

  • 1. Correlation of postabsorptive serum iron increase and erythrocyte-59Fe-incorporation with the whole body retention of absorbed 59Fe.
    Heinrich HC; Fischer R
    Klin Wochenschr; 1982 Dec; 60(24):1493-6. PubMed ID: 6820097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of trivalent iron in oral iron preparations. Therapeutic efficacy and iron absorption from simple ferric compounds and high- or low-molecular weight ferric hydroxide-carbohydrate complexes.
    Heinrich HC
    Arzneimittelforschung; 1975 Mar; 25(3):420-6. PubMed ID: 1174047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal absorption of 59Fe from neutron-activated commercial oral iron(III)-citrate and iron(III)-hydroxide-polymaltose complexes in man.
    Heinrich HC
    Arzneimittelforschung; 1987 Jan; 37(1A):105-7. PubMed ID: 3566863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal iron absorption determined by means of whole body counting and red cell incorporation of 59Fe.
    Larsen L; Milman N
    Acta Med Scand; 1975 Oct; 198(4):271-4. PubMed ID: 811086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantitative measurement of 59Fe-absorption. Comparison between iron labelled Parkevit-Fe and an iron-mono-preparation using a wholebody counter (author's transl)].
    Bräuer H
    MMW Munch Med Wochenschr; 1981 Jan; 123(5):181-3. PubMed ID: 6780894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations.
    Kaltwasser JP; Werner E; Niechzial M
    Arzneimittelforschung; 1987 Jan; 37(1A):122-9. PubMed ID: 3566867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron absorption after renal transplantation.
    Milman N; Larsen L
    Acta Med Scand; 1976; 200(1-2):25-30. PubMed ID: 785958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron absorption in patients with chronic uraemia. A comparative study using whole body counting and red cell incorporation of radioiron.
    Milman N
    Scand J Haematol; 1982 Jul; 29(1):5-17. PubMed ID: 6812212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron absorption in patients with chronic renal failure not requiring dialytic therapy.
    Milman N; Larsen L
    Acta Med Scand; 1975 Dec; 198(6):511-7. PubMed ID: 1211219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of oral iron drugs as judged by a 59Fe-whole-body counting technique in patients with iron deficiency anaemia. Therapeutic efficacy of iron(II)-glycine sulfate.
    Nielsen P; Kongi R; Buggisch P; Fischer R
    Arzneimittelforschung; 2005; 55(7):376-81. PubMed ID: 16080276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of iron and cyanide from 59Fe- and 14C-labelled hexacyanoferrates(II) in rats.
    Nielsen P; Dresow B; Fischer R; Heinrich HC
    Z Naturforsch C J Biosci; 1990 Jun; 45(6):681-90. PubMed ID: 2400471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of some carbohydrates on iron absorption.
    Pabón de Rozo M; VanCampen D; Miller DD
    Arch Latinoam Nutr; 1986 Dec; 36(4):688-700. PubMed ID: 3124780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of iron from (3,5,5-trimethylhexanoyl)ferrocene in rats. A dietary model for severe iron overload.
    Nielsen P; Heinrich HC
    Biochem Pharmacol; 1993 Jan; 45(2):385-91. PubMed ID: 8435091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous measurement of 59Fe and 51Cr in iron absorption studies using a whole-body scanner with mobile shielding.
    Marx JJ; van den Beld B; van Dongen R; Strackee LH
    Nuklearmedizin; 1980 Jul; 19(3):140-5. PubMed ID: 6780983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of bi- and trivalent oral iron preparations. Investigations of iron absorption by postabsorption serum iron concentrations curves.
    Dietzfelbinger H
    Arzneimittelforschung; 1987 Jan; 37(1A):107-12. PubMed ID: 3566864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of iron from oral ferric polymaltose in humans.
    Nielsen P; Gabbe EE; Fischer R; Heinrich HC
    Arzneimittelforschung; 1994 Jun; 44(6):743-8. PubMed ID: 8053973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron absorption from soybean ferritin in nonanemic women.
    Lönnerdal B; Bryant A; Liu X; Theil EC
    Am J Clin Nutr; 2006 Jan; 83(1):103-7. PubMed ID: 16400057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal uptake, mucosal transfer and retention of a therapeutic dose of iron.
    Marx JJ; Stiekema J
    Eur J Clin Pharmacol; 1982 Oct; 23(4):335-8. PubMed ID: 7173303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bioavailability of iron in oral iron preparations. Principles of duration and dosage (author's transl)].
    Heinrich HC; Gabbe EE
    MMW Munch Med Wochenschr; 1979 Aug; 121(35):1104-8. PubMed ID: 114773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inorganic zinc and the intestinal absorption of ferrous iron.
    Crofton RW; Gvozdanovic D; Gvozdanovic S; Khin CC; Brunt PW; Mowat NA; Aggett PJ
    Am J Clin Nutr; 1989 Jul; 50(1):141-4. PubMed ID: 2502004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.